Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
Clinical trial NCT02478502 · TERMINATED
Trial details
- NCT number
- NCT02478502
- Sponsor
- University Hospital, Akershus
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2022-12-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.